A1cNow, the first handheld monitor for testing glycosylated hemoglobin (HbA1c)
June 2001
There's lots of excitement about A1cNow, the first handheld monitor for testing glycosylated hemoglobin (HbA1c).
Experts put a lot of emphasis on monitoring glycosylated hemoglobin. Using HbA1c to get a 2 to 3 month picture of glycemic control helps determine appropriate therapy.
The Amer Diabetes Assoc recommends shooting for an HbA1c < 7%.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote